You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明康德(02359.HK):2019年A股激勵計劃調整後首次授予股票期權第一個行權期行權條件成就
格隆匯 06-03 21:59

格隆匯6月3日丨藥明康德(02359.HK)公佈,根據調整後首次授予授出的股票期權共有三批。授出各批次股票期權的等待期分別為自調整後首次授予之日起18個月、30個月及42個月。

由於調整後首次授予授出股票期權於2019年11月25日進行,故調整後首次授予授出的股票期權的第一個等待期已於2021年5月24日屆滿。實施2020年利潤分配方案後,調整後首次授予授出的股票期權的第一個行權期為2021年6月9日至2022年5月25日。

於第一個行權期,376名調整後激勵對象已達到個人績效要求並達成調整後首次授予授出的股票期權的行權條件。截至調整後首次授予授出的股票期權的第一個等待期屆滿之日(即2021年5月24日),並無發生不可行權的情形。

監於上述情況,調整後首次授予授出的股票期權的第一個行權期行權條件已成就,合共2,390,426份(在2020年利潤分配方案實施的前提下將調整為2,868,385份)股票期權可由376名調整後激勵對象於第一個行權期行權。調整後激勵對象必須在行權期內行使股票期權。若未在行權期內行使股票期權,相關股票期權由公司註銷。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account